ENVERIC BIOSCIENCES
Enveric Biosciences is a patient-centric biotechnology company endeavoring to enhance the lives of those who are adversely affected by the side effects of cancer treatments. Enveric Biosciences has set out with the goal of rigorously testing natural compounds, starting with cannabinoids, to provide patients and clinicians with novel prescription medicines to serve these unmet medical needs.
ENVERIC BIOSCIENCES
Industry:
Biotechnology Health Care Life Science Medical
Founded:
1994-01-01
Address:
Naples, Florida, United States
Country:
United States
Website Url:
http://www.enveric.com
Total Employee:
251+
Status:
Active
Contact:
239-302-1707
Email Addresses:
[email protected]
Total Funding:
40.84 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-05-24 | MagicMed Industries | MagicMed Industries acquired by Enveric Biosciences | 4 M CAD |
Key Employee Changes
| Date | New article |
|---|---|
| 2021-12-06 | Enveric Biosciences Appoints Dr. Bob Dagher as Chief Medical Officer |
Official Site Inspections
http://www.enveric.com Semrush global rank: 3.07 M Semrush visits lastest month: 5.26 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Enveric Biosciences"
Company Overview – Enveric Biosciences
Enveric has been able to optimize its discovery efforts and narrow down the potential compound variations in order to select the best neuroplastogen candidate molecules for specific …See details»
Investors – Enveric Biosciences
Leveraging its unique discovery and development platform, Psybrary™, Enveric has created a robust intellectual property portfolio of novel molecules for specific mental health indications. …See details»
Enveric Biosciences - Crunchbase Company Profile & Funding
Enveric Biosciences is a patient-centric biotechnology company endeavoring to enhance the lives of those who are adversely affected by the side effects of cancer treatments. Enveric …See details»
Enveric Biosciences Reports Financial Results and Provides …
1 day ago CAMBRIDGE, Mass., March 31, 2025--Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company dedicated to the development of …See details»
Enveric Biosciences (ENVB) Company Profile & Description - Stock …
Mar 24, 2025 Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction …See details»
Enveric Biosciences Reports Financial Results and Provides
7 hours ago A discussion of these and other factors, including risks and uncertainties with respect to Enveric, is set forth in Enveric’s filings with the Securities and Exchange …See details»
Enveric Biosciences - Overview, News & Similar companies
May 21, 2024 Who is Enveric Biosciences. Enveric Biosciences is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the …See details»
Enveric Biosciences, Inc. (ENVB) - Yahoo Finance
See the company profile for Enveric Biosciences, Inc. (ENVB) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Enveric Biosciences Reports Financial Results and Provides …
1 day ago CAMBRIDGE, Mass. – Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel …See details»
Enveric Biosciences Reports Financial Results and Provides …
1 day ago CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel …See details»
Enveric Biosciences, Inc. - LinkedIn
Enveric Biosciences, Inc. | 3,134 followers on LinkedIn. A New Approach to Solving Mental Health Challenges | Enveric Biosciences (NASDAQ: ENVB) is a biotechnology company dedicated to …See details»
Enveric Biosciences Inc, SLZG:BER profile - FT.com - Financial Times
Jan 27, 2025 Enveric Biosciences, Inc. is a biotechnology company. The Company is engaged in the development of novel neuroplastogenic small-molecule therapeutics for the treatment of …See details»
Enveric Biosciences - Craft
Enveric Biosciences Summary. Company Summary. Overview. Enveric Biosciences is a biotechnology company that specializes in drug development solutions. It develops …See details»
Enveric Biosciences, Inc. (ENVB) - Yahoo Finance Canada
Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Its …See details»
Corporate Governance – Enveric Biosciences
Mar 18, 2025 George Kegler Director, Chair of the Audit Committee. Mr. Kegler was employed by Mallinckrodt Pharmaceuticals from January 2013 – June 2019, serving as the Executive …See details»
Enveric Biosciences CEO Issues Letter to Shareholders
Feb 27, 2025 Enveric Biosciences, a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of anxiety, depression, …See details»
Enveric Biosciences Reports Financial Results and Provides …
1 day ago Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics …See details»
Enveric Biosciences - Overview, News & Similar companies
May 20, 2024 Enveric Biosciences to Participate in BIO International Convention 2024 CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” …See details»
Enveric Biosciences Reports Financial Results and Provides …
1 day ago Enveric Biosciences ("Enveric" or the "Company"), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the …See details»
Enveric posts $9.5M loss for 2024, but revenue could be on …
17 hours ago Florida-based psychedelics firm Enveric Biosciences (NASDAQ: ENVB), which is still in the pre-revenue stage, this week reported a $9.5 million net loss for 2024, down from …See details»